Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells.
Dean MJ, Ochoa JB, Sanchez-Pino MD, Zabaleta J, Garai J, Del Valle L, Wyczechowska D, Baiamonte LB, Philbrook P, Majumder R, Vander Heide RS, Dunkenberger L, Thylur RP, Nossaman B, Roberts WM, Chapple AG, Wu J, Hicks C, Collins J, Luke B, Johnson R, Koul HK, Rees CA, Morris CR, Garcia-Diaz J, Ochoa AC.
Dean MJ, et al. Among authors: ochoa ac, ochoa jb.
Front Immunol. 2021 Jul 14;12:695972. doi: 10.3389/fimmu.2021.695972. eCollection 2021.
Front Immunol. 2021.
PMID: 34341659
Free PMC article.